Replies to post #61347 on Amarin Corp Plc (AMRN)

[Invest83838]

Thank You Sam!


Hopefully this will bump up the price back to 2.5.

[rafunrafun]

Is it a typo when it says that "FDA suggested that positive outcome in RI could lead to the formal approval of the ANCHOR indication?" - Shouldn't it be REDUCE-IT indication, not ANCHOR indication?

Thanks, SAM

[rafunrafun]

MOG, would love to read your thoughts on the presentation? It just negated pretty much everything that you've been posting.

[ggwpq]

Thanks Sam for the report. A few nuggets from the report:

1) AMRN commented that they were considering strategies to facilitate patient access when payors pushback on covering
Vascepa.

2) the company remains confident Vascepa will show a positive effect on cardiovascular outcomes by the time the trial has accrued all events needed for the final analysis in 2017,

3) believe that partnerships for Vascepa in a contingent of international countries could be non-dilutive sources of cash.